BEP3
01 Feb 2021
BEP3
NCT02582697
Ethics: 384.14
Phase 3 Accelerated BEP: A Randomised Phase 3 Trial of Accelerated Versus Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours
University of Sydney
Cancer Type | Neuroendocrine |
---|---|
Trial Type | Treatment |
Phase | Phase III |
Age Range | 11- 45 years |
Sex | Both |
Tumour Stream | - |
Cancer Stage | Locally Recurrent or Locally Advanced, Metastatic or Widespread |
Anticipated Start Date | 2014-02-14 |
Anticipated End Date | 2023-07-01 |
Hospital | Flinders Medical Centre |
---|---|
Clinical Trial Coordinator | Alex Scott-Hoy |
alex.scott-hoy@sa.gov.au | |
Phone | 08 8204 4830 |
Principal Investigator | Dr Ganessan Kichenadasse |
Recruitment Status | Recruiting |
Hospital | The Royal Adelaide Hospital |
---|---|
Clinical Trial Coordinator | Anne Milton |
anne.milton@sa.gov.au | |
Phone | 08 70742342 |
Principal Investigator | - |
Recruitment Status | Recruitment on Hold |